Anne M. Fagan

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Reisa A. Sperling, Paul Aisen, Laurel Beckett et al. · Alzheimer s & Dementia · 2011 · 7.1K citations · Full text

Medicine, Neurology, Neuroscience +17

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

Randall J. Bateman, Chengjie Xiong, Tammie L.S. Benzinger et al. · New England Journal of Medicine · 2012 · 3.8K citations · Full text

Life Sciences, Neurology, Neuroscience +16

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction

Daniel A. Nation, Melanie D. Sweeney, Axel Montagne et al. · Nature Medicine · 2019 · 1.7K citations

Life Sciences, Neurobiology, Neuroscience +13

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ ₄₂ in humans

Anne M. Fagan, Mark A. Mintun, Robert H. Mach et al. · Annals of Neurology · 2005 · 1.3K citations

Life Sciences, Neurology, Neuroscience +16

APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline

Axel Montagne, Daniel A. Nation, Abhay P. Sagare et al. · Nature · 2020 · 1.3K citations · Full text

Medicine, Neurology, Neuroscience +14